Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181.
- DOI
- 10.1016/j.tjpad.2026.100664
- Published
- 2026 Aug 28
- Container
- The journal of prevention of Alzheimer's disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.tjpad.2026.100664,
title = {Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181.},
author = {Noguchi-Shinohara M and Muramatsu D and Shima A and Sakashita Y and Tada Y and Yamaguchi H and Komatsu J and Ikeda T and Ono K},
year = {2026},
journal = {The journal of prevention of Alzheimer's disease},
doi = {10.1016/j.tjpad.2026.100664},
url = {https://doi.org/10.1016/j.tjpad.2026.100664}
}RIS
TY - JOUR TI - Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181. AU - Noguchi-Shinohara M AU - Muramatsu D AU - Shima A AU - Sakashita Y AU - Tada Y AU - Yamaguchi H AU - Komatsu J AU - Ikeda T AU - Ono K PY - 2026 JO - The journal of prevention of Alzheimer's disease DO - 10.1016/j.tjpad.2026.100664 UR - https://doi.org/10.1016/j.tjpad.2026.100664 ER -
APA
M, N., D, M., A, S., Y, S., Y, T., H, Y., J, K., T, I., & K, O. (2026). Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181.. The journal of prevention of Alzheimer's disease. https://doi.org/10.1016/j.tjpad.2026.100664
Source records
- pubmed · retrieved 2026-09-25T15:01:11.736Z
- europe-pmc · retrieved 2026-09-25T15:01:12.140Z